• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, August 26, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Detecting COVID-19 antibodies in 10-12 seconds

Bioengineer by Bioengineer
January 8, 2021
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Advanced Manufacturing and Materials Lab, College of Engineering, Carnegie Mellon University

PITTSBURGH–Researchers at Carnegie Mellon University report findings on an advanced nanomaterial-based biosensing platform that detects, within seconds, antibodies specific to SARS-CoV-2, the virus responsible for the COVID-19 pandemic. In addition to testing, the platform will help to quantify patient immunological response to the new vaccines with precision.

The results were published this week in the journal Advanced Materials. Carnegie Mellon’s collaborators included the University of Pittsburgh (Pitt) and the UPMC.

The testing platform identifies the presence of two of the virus’ antibodies, spike S1 protein and receptor binding domain (RBD), in a very small drop of blood (about 5 microliters). Antibody concentrations can be extremely low and still detected below one picomolar (0.15 nanograms per milliliter). This detection happens through an electrochemical reaction within a handheld microfluidic device which sends results almost immediately to a simple interface on a smart phone.

“We utilized the latest advances in materials and manufacturing such as nanoparticle 3D printing to create a device that rapidly detects COVID-19 antibodies,” said Rahul Panat, an associate professor of mechanical engineering at Carnegie Mellon who uses specialized additive manufacturing techniques for research ranging from brain-computer interfaces to biomonitoring devices.

An additive manufacturing technology called aerosol jet 3D printing is responsible for the efficiency and accuracy of the testing platform. Tiny, inexpensive gold micropillar electrodes are printed at nanoscale using aerosol droplets that are thermally sintered together. This causes a rough, irregular surface that provides increased surface area of the micropillars and an enhanced electrochemical reaction, where antibodies can latch on to antigens coated on the electrode. The specific geometry allows the micropillars to load more proteins for detection, resulting in very accurate, quick results.

The test has a very low error rate because the binding reaction between the antibody and antigen used in the device is highly selective. The researchers were able to exploit this natural design to their advantage.

The results come at an urgent time during the COVID-19 pandemic. “Because our technique can quantify the immune response to vaccination, it is very relevant in the current environment,” Panat said.

Panat collaborated with Shou-Jiang Gao, leader of the cancer virology program at UPMC’s Hillman Cancer Center and professor of microbiology and molecular genetics at Pitt. Azahar Ali, a researcher in Panat’s Advanced Manufacturing and Materials Lab, was the lead author of the study.

Rapid diagnosis for the treatment and prevention of communicable diseases is a public health issue that goes beyond the current COVID-19 pandemic. Because the proposed sensing platform is generic, it can be used for the rapid detection of biomarkers for other infectious agents such as Ebola, HIV, and Zika. Such a quick and effective test could be a game-changer for controlling the spread of diseases.

###

Reference: “Sensing of COVID-19 antibodies in seconds via aerosol jet nanoprinted reduced graphene oxide coated three dimensional electrodes,” Advanced Materials. https://onlinelibrary.wiley.com/doi/full/10.1002/adma.202006647

About Carnegie Mellon University, College of Engineering: The College of Engineering at Carnegie Mellon University is a top-ranked engineering college that is known for our intentional focus on cross-disciplinary collaboration in research. The College is well known for working on problems of both scientific and practical importance. Our “maker” culture is ingrained in all that we do, leading to novel approaches and transformative results. Our acclaimed faculty has a focus on innovation management and engineering to yield transformative results that will drive the intellectual and economic vitality of our community, nation and world.

Media Contact
Lisa Kulick
[email protected]

Related Journal Article

http://dx.doi.org/10.1002/adma.202006647

Tags: Biomedical/Environmental/Chemical EngineeringBiotechnologyEpidemiologyMechanical EngineeringMedicine/HealthNanotechnology/MicromachinesResearch/DevelopmentTechnology/Engineering/Computer ScienceVirology
Share12Tweet8Share2ShareShareShare2

Related Posts

Targeting Glioblastoma: Ferroptosis Mechanisms and Therapies

August 26, 2025

Rural Health Care Outcomes Accelerator Program Secures Extension Through 2028

August 26, 2025

Central Vein Stenosis: Effects on Dialysis Access

August 26, 2025

C-Terminal Truncations Impact Alpha-Synuclein Pathology

August 26, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    147 shares
    Share 59 Tweet 37
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    142 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    115 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Targeting Glioblastoma: Ferroptosis Mechanisms and Therapies

Pediatric Acute Kidney Injury from Iodinated Contrast

Rural Health Care Outcomes Accelerator Program Secures Extension Through 2028

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.